Day: November 24, 2021

MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — SharpLink Gaming Ltd. (Nasdaq:SBET) (“SharpLink” or the “Company”), a pioneer of game-changing technological solutions and experienced-based services for the U.S. online sports betting industry, today announced that SharpLink CEO Rob Phythian will join other leading industry experts and influencers on a featured panel at the SBC Summit North America 2021 to be held next week at the Meadowlands Exposition Center in New Jersey. The SBC Summit North America conference and expo will bring together all the major players in the fast-growing North American sports betting and igaming industry for two days of high level discussions, business meetings and networking. The conference features senior executives from leading operators, regulators and sports organizations, who will share their insights...

Atossa’s CEO & Founder, Dr. Steven Quay, M.D., Ph.D. & Kyle Guse, GC & CFO will address a series of questions regarding Atossa’s research programs and future developments SEATTLE, Nov. 24, 2021 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announces that Atossa’s CEO, Dr. Steven Quay, M.D., Ph.D., and Kyle Guse, GC & CFO will present at Tribe Public’s Webinar Presentation and Q&A Event that is scheduled to begin at 8am pacific/11am eastern on Tuesday, November 30th.  During this complimentary event, Atossa management will speak at a Q&A session focused on Atossa’s research programs and future development. To...

OVERLAND PARK, Kan., Nov. 24, 2021 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) announced today that Darren Hawkins, Chief Executive Officer, and Dan Olivier, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 1, 2021, at 2:00 p.m. ET, at the Stephens Annual Investment Conference in Nashville, Tennessee. On Friday, December 3, 2021, at 9:30 a.m. ET, Messrs. Hawkins and Olivier will participate in a fireside chat at the virtual Credit Suisse 9th Annual Industrials Conference. These events will be available on the Yellow Corporation website www.myyellow.com as a live audio webcast and as a replay for 30 days. About Yellow Corporation Yellow Corporation has one of the largest, most comprehensive logistics and less-than-truckload (LTL) networks in North America with local, regional, national,...

Company Will Invest in Development of European Green Hydrogen Ecosystem LATHAM, N.Y. and DUISBURG, Germany , Nov. 24, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen market, announced its European headquarters will be located in the Port of Duisburg, North Rhine-Westphalia, Germany. With a significant presence in Europe for more than ten years, Plug Power is accelerating its investment on the continent to develop and grow the green hydrogen economy through a new European headquarters. Duisburg, the world’s largest inland port, offers the company direct maritime supply chain connections to Antwerp, Belgium and Rotterdam, Netherlands. This location will allow Plug Power to capitalize on the major assets of the Duisburg region’s industrial...

OXFORD, United Kingdom, Nov. 24, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that Bill Enright, Chief Executive Officer, and Georgy Egorov, Chief Financial Officer, are participating at the 33rd Annual Virtual Piper Sandler Healthcare Conference November 30th to December 2nd, 2021. A pre-recorded fireside chat with Bill Enright and Georgy Egorov is available at the link below.Event: 33rd Piper Sandler Annual Healthcare ConferenceFireside Chat: Virtual on-demand webcastTime/date: 10 a.m. EST, Nov. 22 and available for approximately 90 daysWebcast: Events section of the Vaccitech websiteAbout Vaccitech plcVaccitech is a clinical-stage biopharmaceutical company engaged...

Focus on the discovery and development of novel therapeutic strategies to treat obesity and its related metabolic disorders TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or the “Company”), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce it has signed an agreement to fund a new research and development project with the Hebrew University of Jerusalem’s Obesity and Metabolism Laboratory, to evaluate the Company’s proprietary compound, MEAI’s direct effect on binge eating including food and water intakes as well as activity and metabolic parameters. The study, which will be overseen by Prof. Joseph (Yossi)...

Over 9 months of 2021, Grigeo AB group (hereinafter – the Group), consisting of Grigeo AB, Grigeo Packaging UAB, Grigeo Baltwood UAB, Grigeo Klaipėda AB, Mena Pak AT, Grigeo Recycling UAB, Grigeo Recycling SIA and Grigeo investicijų valdymas UAB achieved the consolidate sales turnover of EUR 117.8 million. It is by EUR 21.0 million more than over 9 months of 2020. Over the reporting period, the Group earned EUR 11.7 million profit before taxes, which is by EUR 2.6 million more than in the same period in 2020. Earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Group, if compared with 9 months of 2021, increased by EUR 1.4 million and reached EUR 19.2 million. Over 9 months of 2021, Grigeo AB (hereinafter – the Company) sales amounted to EUR 48.8 million, which is by EUR 0.9 million more than in the same period...